Breast Biopsy Devices Market Size, Trends, Analysis, and Outlook By Type (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others), By Procedure (Needle Breast Biopsy, Open Surgical Breast Biopsy,

Breast Biopsy Devices Market Size, Trends, Analysis, and Outlook By Type (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others), By Procedure (Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy), By Technique (Image Guided Biopsy, Liquid Biopsy), By Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By End-User (Hospitals, Surgical Centers, Breast Care Centers, Diagnostic Centers, Others), by Country, Segment, and Companies, 2024-2032

The global Breast Biopsy Devices market size is poised to register 9.1% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Breast Biopsy Devices market across By Type (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others), By Procedure (Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy), By Technique (Image Guided Biopsy, Liquid Biopsy), By Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By End-User (Hospitals, Surgical Centers, Breast Care Centers, Diagnostic Centers, Others)

The breast biopsy devices market is driven by the increasing incidence of breast cancer, advancements in minimally invasive biopsy techniques, and the need for accurate tissue sampling for diagnosis and treatment planning. By 2030, the market is expected to witness steady growth, fueled by innovations in vacuum-assisted biopsy (VAB), core needle biopsy (CNB), and ultrasound-guided biopsy systems. Further, expanding applications in breast cancer screening, lesion characterization, and molecular profiling are anticipated to drive market expansion, enabling clinicians to obtain tissue specimens safely and efficiently, leading to earlier detection, personalized treatment approaches, and improved outcomes for patients with breast cancer.

Breast Biopsy Devices Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Breast Biopsy Devices market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Breast Biopsy Devices survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Breast Biopsy Devices industry.

Key market trends defining the global Breast Biopsy Devices demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Breast Biopsy Devices Market Segmentation- Industry Share, Market Size, and Outlook to 2032

The Breast Biopsy Devices industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Breast Biopsy Devices companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Breast Biopsy Devices industry

Leading Breast Biopsy Devices companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Breast Biopsy Devices companies.

Breast Biopsy Devices Market Study- Strategic Analysis Review

The Breast Biopsy Devices market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-

• Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
• Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
• Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
• Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.

Breast Biopsy Devices Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Breast Biopsy Devices industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.

Breast Biopsy Devices Country Analysis and Revenue Outlook to 2032

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.

North America Breast Biopsy Devices Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Breast Biopsy Devices market segments. Similarly, Strong market demand is encouraging Canadian Breast Biopsy Devices companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Breast Biopsy Devices market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Breast Biopsy Devices Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Breast Biopsy Devices industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Breast Biopsy Devices market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Breast Biopsy Devices Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Breast Biopsy Devices in Asia Pacific. In particular, China, India, and South East Asian Breast Biopsy Devices markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.

Latin America Breast Biopsy Devices Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Breast Biopsy Devices Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Breast Biopsy Devices market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Breast Biopsy Devices.

Breast Biopsy Devices Market Company Profiles

The global Breast Biopsy Devices market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Argon Medical Devices Inc, Becton Dickinson and Company, Biocept Inc, Bio-Rad Laboratories Inc, Danaher Corp, Exact Sciences Corp, F. Hoffmann-La Roche Ltd, Guardant Health Inc, Hologic Inc, Menarini-Silicon Biosystems S.p.A., Merit Medical Systems Inc, NeoGenomics Laboratories Inc, QIAGEN N.V., Sterylab S.R.L., Sysmex Inostics GmbH.

Recent Breast Biopsy Devices Market Developments

The global Breast Biopsy Devices market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Breast Biopsy Devices Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis

• Pricing Analysis
• Value Chain Analysis
• SWOT Profile
• Market Dynamics- Trends, Drivers, Challenges
• Porter’s Five Forces Analysis
• Macroeconomic Impact Analysis
• Case Scenarios- Low, Base, High

Market Segmentation:

By Type

Biopsy Needles

Guidance Systems

Biopsy Tables

Localization Wires

Assay Kits

Liquid Biopsy Instruments

Others

By Procedure

Needle Breast Biopsy

-Core-Needle Biopsy (CNB)

-Fine-Needle Aspiration Biopsy (FNAB)

-Vacuum-Assisted Biopsy (VAB)

Open Surgical Breast Biopsy

-Excisional

-Incisional

Liquid Breast Biopsy

-Circulating Tumor Cells

-Circulating Tumor DNA (CtDNA)

-Others

By Technique

Image Guided Biopsy

Liquid Biopsy

By Application

Early Cancer Screening

Therapy Selection

Treatment Monitoring

Recurrence Monitoring

By End-User

Hospitals

Surgical Centers

Breast Care Centers

Diagnostic Centers

Others

Geographical Segmentation:

• North America (3 markets)
• Europe (6 markets)
• Asia Pacific (6 markets)
• Latin America (3 markets)
• Middle East Africa (5 markets)

Companies

Argon Medical Devices Inc

Becton Dickinson and Company

Biocept Inc

Bio-Rad Laboratories Inc

Danaher Corp

Exact Sciences Corp

F. Hoffmann-La Roche Ltd

Guardant Health Inc

Hologic Inc

Menarini-Silicon Biosystems S.p.A.

Merit Medical Systems Inc

NeoGenomics Laboratories Inc

QIAGEN N.V.

Sterylab S.R.L.

Sysmex Inostics GmbH

Formats Available: Excel, PDF, and PPT